Occlutech Progress in US – First Patient has been Enrolled in Important US FDA Study

SCHAFFHAUSEN, CH / ACCESSWIRE / May 12, 2022 / Occlutech Holding AGOcclutech Holding AG ("Occlutech"), one of the world's leading providers of minimally invasive structural heart disease implants, continues its progress in the US market. The company …